<DOC>
	<DOC>NCT02023242</DOC>
	<brief_summary>This clinical trial compares two implantable devices intended to lower the pressure inside the eye of glaucoma patients.</brief_summary>
	<brief_title>Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes</brief_title>
	<detailed_description>This is a prospective, multicenter, single-masked, randomized clinical trial comparing the Hydrus Microstent to two iStent implants for the reduction of intraocular pressure in phakic patients with a positive diagnosis of primary open angle glaucoma, pseudoexfoliative glaucoma, or pigmentary dispersion glaucoma. Post-operative follow-up visits will be conducted at regular intervals.</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<criteria>A diagnosis of primary open angle glaucoma (POAG), Pseudoexfoliative (PXG) glaucoma, or Pigmentary glaucoma (PG) A phakic lens with BCVA of 20/30 or better Forms of primary or secondary glaucoma not listed above Prior glaucoma surgery in the study eye</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Primary open angle glaucoma</keyword>
	<keyword>POAG</keyword>
	<keyword>Pseudoexfoliative glaucoma</keyword>
	<keyword>PXG</keyword>
	<keyword>Pigmentary glaucoma</keyword>
	<keyword>PG</keyword>
	<keyword>Hydrus</keyword>
</DOC>